Pillstats
Rx only · Kit

Rivaroxaban

Brands: Xarelto

2 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US3 NDCs
2 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATCB01AF01
RxCUI (US)1114195
US makers2 labelers
Packages4
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 1 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$5.61$11.23$16.84$22.45Dec 2025Jun 2026Jul 2026
$19.466
Latest avg · Jul 22, 2026
+2%
Since Dec 17, 2025
2
Active US suppliers
100%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

6431.3K1.9K2.6K2025 Q12025 Q22025 Q32025 Q42026 Q1
1.6K
Rx · 2026 Q1
79K
Units dispensed
-26%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it2 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Alembic Pharmaceuticals Limitedunknown2SUPPLYING
Janssen Pharmaceuticals, Inc.unknown2SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.